Aptose Biosciences Inc. held its Annual and Special Meeting of Shareholders, where shareholders voted in favor of all items of business, including the election of directors, appointment of independent registered public accounting firm, approval of executive compensation, approval of potential issuance of common shares, and approval of meeting adjournments.